相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exploring the binding modes of cordycepin to human adenosine deaminase 1 (ADA1) compared to adenosine and 2'-deoxyadenosine
Jitti Niramitranon et al.
JOURNAL OF MOLECULAR MODELING (2020)
NUC-1031 in biliary tract cancer: from bench to bedside and back?
Lenka N. C. Boyd et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
Life, death, and autophagy in cancer: NF-κB turns up everywhere
Daniela Verzella et al.
CELL DEATH & DISEASE (2020)
NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121)
Mairead Geraldine McNamara et al.
FUTURE ONCOLOGY (2020)
NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trials
Zainul Abedin Kapacee et al.
MEDICAL ONCOLOGY (2020)
Mechanism of Activation of AMPK by Cordycepin
Simon A. Hawley et al.
CELL CHEMICAL BIOLOGY (2020)
Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031
Awa Sarr et al.
SCIENTIFIC REPORTS (2019)
A novel nucleoside rescue metabolic pathway may be responsible for therapeutic effect of orally administered cordycepin
Jong Bong Lee et al.
SCIENTIFIC REPORTS (2019)
The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritis
Sadaf Ashraf et al.
SCIENTIFIC REPORTS (2019)
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study
Sarah P. Blagden et al.
BRITISH JOURNAL OF CANCER (2018)
Cordycepin induces apoptosis in human pancreatic cancer cells via the mitochondrial-mediated intrinsic pathway and suppresses tumor growth in vivo
Yu Zhang et al.
ONCOTARGETS AND THERAPY (2018)
The Anticancer Properties of Cordycepin and Their Underlying Mechanisms
So Young Yoon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Identification of cordycepin biosynthesis-related genes through de novo transcriptome assembly and analysis in Cordyceps cicadae
Tengfei Liu et al.
ROYAL SOCIETY OPEN SCIENCE (2018)
NF-κB, inflammation, immunity and cancer: coming of age
Koji Taniguchi et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Cordycepin induces apoptosis of human ovarian cancer cells by inhibiting CCL5-mediated Akt/NF-κB signaling pathway
Zhen Yang Cui et al.
CELL DEATH DISCOVERY (2018)
Cordycepin induces cell cycle arrest and apoptosis by inducing DNA damage and up-regulation of p53 in Leukemia cells
Yuanhong Liao et al.
CELL CYCLE (2015)
Apoptosis and inhibition of proliferation of cancer cells induced by cordycepin (Review)
Xuewen Tian et al.
ONCOLOGY LETTERS (2015)
Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances
Gen Li et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Metabolism and Pharmacokinetics of the Anti-Hepatitis C Virus Nucleotide Prodrug GS-6620
Eisuke Murakami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Breast
Patrick L. Fitzgibbons et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line
Patrick Essletzbichler et al.
GENOME RESEARCH (2014)
Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical Development
Magdalena Slusarczyk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Apoptosis induction of human prostate carcinoma cells by cordycepin through reactive oxygen species-mediated mitochondrial death pathway
Hye Hyeon Lee et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Cordycepin: A bioactive metabolite with therapeutic potential
Hardeep S. Tuli et al.
LIFE SCIENCES (2013)
A reversible gene trap collection empowers haploid genetics in human cells
Tilmann Buerckstuemmer et al.
NATURE METHODS (2013)
Deciphering the Glycosylome of Dystroglycanopathies Using Haploid Screens for Lassa Virus Entry
Lucas T. Jae et al.
SCIENCE (2013)
Species difference of esterase expression and hydrolase activity in plasma
Fatma Goksin Bahar et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Inhibition of polyadenylation reduces inflammatory gene induction
Alexander Kondrashov et al.
RNA (2012)
The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2′-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes
Johan Vande Voorde et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Phosphoramidate ProTides of the Anticancer Agent FUDR Successfully Deliver the Preformed Bioactive Monophosphate in Cells and Confer Advantage over the Parent Nucleoside
Christopher McGuigan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
NF-κB addiction and its role in cancer: 'one size does not fit all'
M. M. Chaturvedi et al.
ONCOGENE (2011)
Pharmacokinetics of Adenosine and Cordycepin, a Bioactive Constituent of Cordyceps sinensis in Rat
Yung-Jen Tsai et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
Oncogenic Activation of NF-kappa B
Louis M. Staudt
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Haploid Genetic Screens in Human Cells Identify Host Factors Used by Pathogens
Jan E. Carette et al.
SCIENCE (2009)
Cordyceps - A traditional Chinese medicine and another fungal therapeutic biofactory?
R. Russell M. Paterson
PHYTOCHEMISTRY (2008)
Molecular modelling studies on the binding of some protides to the putative human phosphoramidase Hint1
C. Congiatu et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2007)
Pharmacological actions of Cordyceps, a prized folk medicine
TB Ng et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2005)
IκB kinases:: key regulators of the NF-κB pathway
Y Yamamoto et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
High constitutive level of NF-κB is crucial for viability of adenocarcinoma cells
AS Smirnov et al.
CELL DEATH AND DIFFERENTIATION (2001)
分享论文
